Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Dec 9, 2025

Dissecting Mechanoenzymatic Properties of Processive Myosins with Ultrafast Force-Clamp Spectroscopy

Dissecting Mechanoenzymatic Properties of Processive Myosins with Ultrafast Force-Clamp Spectroscopy

Published on: July 1, 2021

Reply to M. Hertzberg et al

Mark Roschewski¹, Kieron Dunleavy¹, Wyndham H Wilson¹

¹Mark Roschewski, MD, Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD; Kieron Dunleavy, MD, George Washington University Cancer Center, Washington, DC; and Wyndham H. Wilson, MD, PhD, Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, MD.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|September 15, 2020

Summary

No abstract available in PubMed .

More Related Videos

Cryo-EM and Single-Particle Analysis with Scipion

Cryo-EM and Single-Particle Analysis with Scipion

Published on: May 29, 2021

Related Experiment Videos

Last Updated: Dec 9, 2025

Dissecting Mechanoenzymatic Properties of Processive Myosins with Ultrafast Force-Clamp Spectroscopy

Dissecting Mechanoenzymatic Properties of Processive Myosins with Ultrafast Force-Clamp Spectroscopy

Published on: July 1, 2021

Cryo-EM and Single-Particle Analysis with Scipion

Cryo-EM and Single-Particle Analysis with Scipion

Published on: May 29, 2021

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Meta-analysis of survival by phased-variant ctDNA and PET response in large B-cell lymphoma.

Blood advances·2026

Same author

When will circulating tumor DNA be ready for prime time in lymphoma?

Clinical advances in hematology & oncology : H&O·2026

Same author

Minimal residual disease guided treatment approaches in non-Hodgkin lymphoma-Where we are and where we're headed.

Seminars in hematology·2026

Same author

A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma.

Blood advances·2026

Same author

SOHO State of the Art Updates and Next Questions | Addressing the Transformative Questions in Aggressive B-Cell Lymphomas.

Clinical lymphoma, myeloma & leukemia·2026

Same author

Axes of biological variation in diffuse large B cell lymphoma.

Cancer cell·2026